Recently, more attention has been paid to GLP-1 receptor agonists, medications originally intended for weight loss and diabetes. These drugs stimulate feelings of fullness and thus help to consume fewer calories. It is now being investigated whether they can also contribute to slowing the aging process.
The special thing about GLP-1 medications is that they can lead to a limited calorie intake. Calorie restriction has so far been one of the most effective methods to slow down the aging process in animal studies. The long-term effects of fewer calories are shown to make the body healthier in several ways. This could explain why these medications may have benefits beyond weight loss.
Scientists are still trying to determine whether GLP-1 receptor agonists also prevent direct aging, apart from their effect on calorie restriction. The research results so far are not yet clear enough to draw a firm conclusion about this. It mainly involves better understanding the mechanisms of action in the body and the brain.
For people interested in healthy aging, it is good to know that new treatments sometimes build on well-known principles, such as calorie restriction. This research could eventually lead to new possibilities for living longer healthily, but more evidence is still needed.
Source: Reason
